Pakistan’s medicinal imports rise by 9.74pc
ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...
CCP approves acquisition of two Japanese pharma products by Hilton Pharma
Proposed transaction entails the acquisition of Methycobal and Myonal including their trademarks
Pharmaceuticals in Pakistan: extracting whatever they can from the pie
Can the pharmaceutical sector ever be reformed? Kabeer Dawani and Asad Sayeed take a look at the sector’s pitfalls, and ways forward.
BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead?Â
The pharma company, which has been exporting to countries like Indonesia, Belarus and Ukraine, saw book building at Rs 77/share and oversubscription of 3.4 times.
AGP IPO: Book-building process ends up in strike price of Rs80
LAHORE: The book-building process of the Initial Public Offering (IPO) of AGP Limited, one of Pakistan’s leading pharma companies has resulted in...
DRAP orders urgent recall of substandard medicines, medical products
Contaminated injections, syrups, and IV cannulas flagged; crackdown launched nationwide
Ferozsons strikes deal with Gilead Sciences to produce generic HIV drugÂ
Ferozsons or its affiliates can manufacture and sell lenacapavir in 120 countriesÂ
Where did all the Burnol go?
The household product is missing from pharmacies in Pakistan. But its brand recall still holds
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million...
Pak pharma industry suffers from government’s shackles
A thriving sector in Pakistan’s economy, pharmaceuticals is a $3.2 billion industry, growing at 15% annually, while its exports now at $US200...
LCCI demands DRAP to form a liaison committee
LAHORE: The Lahore Chamber of Commerce and Industry (LCCI) has demanded from the Drug Regulatory Authority of Pakistan (DRAP) to form a...
Seasonal flu pushing up rates of Arinac Forte, Panadol CF
KARACHI: As seasonal flu sets in, demand has surged for Arinac Forte and Panadol CF , used for cold and flu and witnessed...
In the first quarter after deregulation, pharma sector revenue up by 25%
The increase in revenue is driven mostly by price increases as drug manufacturers can finally raise prices based on business need and rising costs instead of regulatory fiat
Oxfam’s damning report puts multinational pharma companies in the dock over tax evasion
Tax Dodgers: In seven developing countries, firms appeared to avoid an estimated $112m in taxes every year
ISLAMABAD: Oxfam International’s damning report confirmed...
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth